Extrait

The primary objective is to estimate the incidence of febrile reactions of ≥38 to ≤39°C; >39 to ≤40°C; >40°C occurring within 2 days following vaccination with Prevenar (PCV-7) coadministered with other routine childhood vaccines under the conditions of routine daily use in the Russian Federation within the licensed indication

Critère d'inclusion

• Infants from 3 months up to 23 months of age who may benefit from active immunization against disease caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F and 23F (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media) and who would be scheduled to receive Prevenar PCV-7

Liens

• euctr